Biotech versus Pharma Perspectives – Clinical Development Strategy


  • Vicki Goodman, MD, EVP, Product Development and Medical Affairs and CMO, Exelixis – to be confirmed
  • Andres McAllister, PhD, CMO, BioInvent
  • Lini Pandite, MD, CMO, Shattuck Labs
  • Mike Rothenberg, MD, PhD, Head, Early Oncology Clinical Development, & Oncology R&D, Pfizer
  • Peter Sandor, MD, SVP, Primary Focus Lead Immuno-oncology, Astellas